GENELABS TECHNOLOGIES
As of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company's product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline;... and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.
GENELABS TECHNOLOGIES
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
1983-01-01
Address:
Redwood City, California, United States
Country:
United States
Website Url:
http://www.genelabs.com
Total Employee:
51+
Status:
Active
Contact:
650-369-9500
Total Funding:
17.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress IPv6 Cloudflare Cloudflare Hosting Cloudflare Network Error Logging Cloudflare DNS Cloudflare SSL
Current Employees Featured
Founder
Investors List
Paramount BioCapital Asset Management
Paramount BioCapital Asset Management investment in Venture Round - Genelabs Technologies
Merlin Biomed
Merlin Biomed investment in Venture Round - Genelabs Technologies
Fort Mason Capital
Fort Mason Capital investment in Venture Round - Genelabs Technologies
RA Capital Management
RA Capital Management investment in Venture Round - Genelabs Technologies
Centrecourt Asset Management
Centrecourt Asset Management investment in Venture Round - Genelabs Technologies
Official Site Inspections
http://www.genelabs.com
- Host name: 172.67.130.47
- IP address: 172.67.130.47
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
